Axogen Inc vs Energy Select Sector SPDR Fund — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Energy Select Sector SPDR Fund trades at $56.89. Which is the better fit depends on your goals.
| AXGN | XLE | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | — |
52-Week High | $46.19 | $62.57 |
52-Week Low | $11.28 | $42.12 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
XLE trades at $56.75, up 3.03% with a bullish technical signal from moving averages and oscillators. The ETF benefits from strong sector performance, ranking among top Sector SPDRs with 21% YTD gains (ETF Trends, July 2, 2026). Recent oil price volatility and geopolitical tensions drive energy sector attention, while a dividend of $0.38 is scheduled for June 2026.
Outlook remains positive due to robust earnings growth expectations in energy, though overbought RSI signals near-term caution. Risks include oil price sensitivity and competition from clean energy ETFs. Analyst sentiment leans bullish with sector fundamentals strengthening amid disciplined capital expenditure and demand drivers.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →